Xtant Medical Holdings
Stock Forecast, Prediction & Price Target
Xtant Medical Holdings Financial Estimates
Xtant Medical Holdings Revenue Estimates
Xtant Medical Holdings EBITDA Estimates
Xtant Medical Holdings Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | ||
Revenue
% change YoY
| $55.26M N/A | $57.96M 4.89% | $91.30M 57.50% | Avg: $134M Low: $128.3M High: $139.7M avg. 46.76% | Avg: $163.1M Low: $159.37M High: $166.82M avg. 21.71% | ||
Net Income
% change YoY
| $-5.84M N/A | $-8.48M -45.19% | $660K 107.77% | Avg: $-1.5M Low: $-1.30M High: $-1.23M avg. -327.27% | Avg: $4M Low: $3.69M High: $3.91M avg. 366.66% | ||
EBITDA
% change YoY
| $-2.52M N/A | $-5.43M -115.38% | $5.07M 193.42% | Avg: $-4.79M Low: $-4.99M High: $-4.58M avg. -194.38% | Avg: $-5.83M Low: $-5.96M High: $-5.69M avg. -21.71% | ||
EPS
% change YoY
| -$0.07 N/A | -$0.09 -31.87% | $0.01 106.09% | Avg: -$0.01 Low: -$0.01 High: -$0.01 avg. -281.81% | Avg: $0.03 Low: $0.03 High: $0.03 avg. 400% | ||
Operating Expenses
% change YoY
| $36.34M N/A | $38.89M 7.01% | $65.62M 68.73% | Avg: $89.09M Low: $85.30M High: $92.88M avg. 35.76% | Avg: $108.44M Low: $105.97M High: $110.92M avg. 21.71% | ||
FAQ
What is Xtant Medical Holdings stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 19.69% in 2025-2026.
We have gathered data from 2 analysts. Their low estimate is -1.30M, average is -1.5M and high is -1.23M.
What is Xtant Medical Holdings stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 34.24% in 2025-2026.
We have gathered data from 2 analysts. Their low revenue estimate is $128.3M, average is $134M and high is $139.7M.
What is Xtant Medical Holdings stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 59.09% in 2025-2026.
We have gathered data from 2 analysts. Their low earnings per share estimate is -$0.01, average is -$0.01 and high is $-0.00.
What is the best performing analyst?
In the last twelve months analysts have been covering Xtant Medical Holdings stock. The most successful analyst is Chase Knickerbocker.